Keywords: costs, drag, losses, lower, regeneron, new, york

R&D costs drag losses lower at Regeneron

Article | 19 May 2003

Print This

New York, USA-based biotechnology concern Regeneron has reported a net loss of $30.1 million, or $0.68 per share, for the first quarter ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in